393 related articles for article (PubMed ID: 38002492)
1. A Review of the Potential of Nuclear Factor [Erythroid-Derived 2]-like 2 Activation in Autoimmune Diseases.
Ates I; Yılmaz AD; Buttari B; Arese M; Saso L; Suzen S
Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002492
[TBL] [Abstract][Full Text] [Related]
2. Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice.
Suzuki T; Murakami S; Biswal SS; Sakaguchi S; Harigae H; Yamamoto M; Motohashi H
Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28507037
[TBL] [Abstract][Full Text] [Related]
3. Patent Review (2017-2020) of the Keap1/Nrf2 Pathway Using PatSeer Pro: Focus on Autoimmune Diseases.
Chartoumpekis DV; Fu CY; Ziros PG; Sykiotis GP
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33212784
[TBL] [Abstract][Full Text] [Related]
4. Effect of redox modulating NRF2 activators on chronic kidney disease.
Choi BH; Kang KS; Kwak MK
Molecules; 2014 Aug; 19(8):12727-59. PubMed ID: 25140450
[TBL] [Abstract][Full Text] [Related]
5. Nrf2: friend and foe in preventing cigarette smoking-dependent lung disease.
Müller T; Hengstermann A
Chem Res Toxicol; 2012 Sep; 25(9):1805-24. PubMed ID: 22686525
[TBL] [Abstract][Full Text] [Related]
6. KEAP1-NRF2 protein-protein interaction inhibitors: Design, pharmacological properties and therapeutic potential.
Crisman E; Duarte P; Dauden E; Cuadrado A; Rodríguez-Franco MI; López MG; León R
Med Res Rev; 2023 Jan; 43(1):237-287. PubMed ID: 36086898
[TBL] [Abstract][Full Text] [Related]
7. Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?
Pompili S; Sferra R; Gaudio E; Viscido A; Frieri G; Vetuschi A; Latella G
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434263
[TBL] [Abstract][Full Text] [Related]
8. Natural Coumarin Derivatives Activating Nrf2 Signaling Pathway as Lead Compounds for the Design and Synthesis of Intestinal Anti-Inflammatory Drugs.
Di Stasi LC
Pharmaceuticals (Basel); 2023 Mar; 16(4):. PubMed ID: 37111267
[TBL] [Abstract][Full Text] [Related]
9. The role of Nrf2 and PPARgamma in the improvement of oxidative stress in hypertension and cardiovascular diseases.
Dovinova I; Kvandová M; Balis P; Gresova L; Majzunova M; Horakova L; Chan JY; Barancik M
Physiol Res; 2020 Dec; 69(Suppl 4):S541-S553. PubMed ID: 33656904
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the Nrf2 Antioxidant Signaling Provides Protection Against Trichloroethene-mediated Inflammation and Autoimmune Response.
Banerjee N; Wang H; Wang G; Khan MF
Toxicol Sci; 2020 May; 175(1):64-74. PubMed ID: 32073640
[TBL] [Abstract][Full Text] [Related]
11. Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases.
Saito H
Biochem Pharmacol; 2013 Apr; 85(7):865-72. PubMed ID: 23333765
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Understanding Nrf2 Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases.
Kim MJ; Jeon JH
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269986
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs.
Telkoparan-Akillilar P; Suzen S; Saso L
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022969
[TBL] [Abstract][Full Text] [Related]
14. Targeting Nrf2/Keap1 signaling pathway by bioactive natural agents: Possible therapeutic strategy to combat liver disease.
Jayasuriya R; Dhamodharan U; Ali D; Ganesan K; Xu B; Ramkumar KM
Phytomedicine; 2021 Nov; 92():153755. PubMed ID: 34583226
[TBL] [Abstract][Full Text] [Related]
15. The Role of Nrf2 in Cellular Innate Immune Response to Inflammatory Injury.
Kim J; Surh YJ
Toxicol Res; 2009 Dec; 25(4):159-173. PubMed ID: 32038834
[TBL] [Abstract][Full Text] [Related]
16. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders.
Kim J; Cha YN; Surh YJ
Mutat Res; 2010 Aug; 690(1-2):12-23. PubMed ID: 19799917
[TBL] [Abstract][Full Text] [Related]
17. An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment.
Keleku-Lukwete N; Suzuki M; Yamamoto M
Antioxid Redox Signal; 2018 Dec; 29(17):1746-1755. PubMed ID: 28899203
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
19. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor erythroid 2-related factor 2 (Nrf2) as a potential therapeutic target for vitiligo.
Lin X; Meng X; Song Z; Lin J
Arch Biochem Biophys; 2020 Dec; 696():108670. PubMed ID: 33186606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
